Physician profile
Unknown Komal
NPI 1235616541
$707.05
in general payments reported to CMS, 2019-2025
17 companies · $643 in 2025
The $643 reported for 2025 was more than what a typical Endocrinology, Diabetes & Metabolism provider received nationally (typical 2025 total: $506).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $63.86 · 2025: $643.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $707.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $707.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $107.18 | 2024-2025 | Wegovy, Ozempic, Rybelsus |
| Dynavax Technologies Corporation | $96.37 | 2025 | Heplisav-B |
| Dexcom, INC. | $82.28 | 2025 | Dexcom G6 Transmitter |
| Sanofi-Aventis U.S. LLC | $68.07 | 2024-2025 | |
| Astrazeneca Pharmaceuticals Lp | $39.22 | 2025 | Saphnelo |
| Amgen INC. | $38.50 | 2025 | Evenity |
| Lilly USA, LLC | $36.99 | 2025 | Mounjaro, Zepbound |
| Bayer Healthcare Pharmaceuticals INC. | $31.41 | 2025 | |
| Ucb, INC. | $28.47 | 2025 | Bimzelx |
| Medtronic, INC. | $26.00 | 2025 | Minimed 780g |
| Tandem Diabetes Care, INC. | $25.16 | 2024 | T:Slim X2 Insulin Pump With Control-Iq |
| Merck Sharp & Dohme LLC | $24.94 | 2025 | Capvaxive, Gardasil 9 |
| Ascendis Pharma Endocrinology INC | $23.49 | 2025 | Yorvipath |
| Exact Sciences Corporation | $21.41 | 2025 | Cologuard Collection Kit |
| Insulet Corporation | $20.83 | 2025 | Omnipod |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $18.84 | 2025 | Freestyle Libre 3 |
| Pfizer INC. | $17.89 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Unknown Komal listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.